Almirall Prodesfarma Key Drug Trials Disappoint Investors

MADRID, Sept 3 (Reuters) - Spanish drug firm Almirall said the results of advanced trials for its key lung disease drug showed it was less effective than in previous trials, sending shares plummeting 18 percent.